Follow-The-Filings

Security · featured owners

TWST

Twist Bioscience Corp. COMMON STOCK Equity as of 2026 Q2 among managers we track

  • 3 Owners
  • Max 3.0%
  • $694M
  • 2 add 1 reduce 1 exit

Who owns this now

Largest portfolio weights among featured holders · max 3.0% (Cathie Wood - Ark Investm...) · not free-float ownership

  1. Cathie Wood reduce 3.0%
  2. Farallon Capital Management add 1.0%
  3. Polen Capital Management add 0.05%

holders

sorted by % of portfolio · long equity only · exits show last held size · open a manager for their book

history
Cathie Wood - Ark Investment Management 2026 Q2 3.0% Reduce −28.3% 4,549,803 $468M hist
Farallon Capital Management 2026 Q2 1.0% Add +49.6% 2,136,400 $220M hist
Polen Capital Management 2026 Q2 0.05% Add +130.1% 55,310 $6M hist
Stanley Druckenmiller - Duquesne Family Office exited 2026 Q2 last 2026 Q1 0.3% Exit −0.29 pp 206,000 $10M hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $245.11M $312.97M $376.57M
Gross profit * $89.73M $133.35M $191M
Gross margin * 36.6% 42.6% 50.7%
Net income -$204.62M -$208.73M -$77.67M
Net margin * -83.5% -66.7% -20.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $424.26M $346.78M $332.97M
Total non-current assets * $352.15M $267.55M $308.9M
Total assets $776.4M $614.32M $641.86M
Total current liabilities $73.32M $71.01M $91.41M
Total non-current liabilities * $79.65M $70.63M $77.5M
Total equity $623.43M $472.69M $472.96M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$142.47M -$64.09M -$47.63M
Cash from investing $50.61M -$3.07M -$24.76M
Cash from financing $911,000 $6.89M $28.54M
Net change in cash -$90.98M -$60.15M -$43.71M

ownership over time

filing count by report period · click a bar for that quarter’s holders